Cite Filings / ROIV / 0001140361-25-045204

Feed Companies Filings Check

Sign in

8-K

Current Report

Roivant Sciences Ltd. Filed 2025-12-11 Acc 0001140361-25-045204

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , ef20061071_8k.htm

Around this filing

2026-02-06 8-K Results of operations
2025-12-12 SCHEDULE 13D/A Beneficial Ownership Report
2025-12-12 4 Director bought 16,666,666 shares at $21.00 ($349,999,986)
2025-12-11 4 President & Immunovant CEO sold 200,000 shares at $20.85 ($4,170,000)
2025-12-11 8-K Regulation FD disclosure
2025-12-09 144 Sale of Securities
2025-11-10 8-K Results of operations

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading ef20061071_8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…